Saurus, Pauliina
Kuusela, Sara
Dumont, Vincent
Lehtonen, Eero
Fogarty, Christopher L.
Lassenius, Mariann I.
Forsblom, Carol
Lehto, Markku
Saleem, Moin A.
Groop, Per-Henrik
Lehtonen, Sanna
Article History
Received: 3 September 2015
Accepted: 14 January 2016
First Online: 15 February 2016
Competing interests
: P-H.G. has received lecture honoraria from Abbot, Boehringer Ingelheim, Cebix, Eli Lilly, Genzyme, Novartis, Novo Nordisk and MSD and research grants from Eli Lilly and Roche. P-H.G. is an advisory board member for Boehringer Ingelheim, Novartis and Medscape. The authors have no additional financial interests.